2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals-Reference-Cited by-同舟云学术

2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals

Published:2015-01-15 Issue:2 Volume:20 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Rondy M¹,Launay O²³⁴,Puig-Barberà J⁵,Gefenaite G⁶⁷,Castilla J⁸⁹,de Gaetano Donati K¹⁰,Galtier F¹¹¹²²,Hak E⁶⁷,Guevara M⁸⁹,Costanzo S¹³,European hospital IVE network Collective¹⁴,Moren A¹

Affiliation:

1. EpiConcept, Paris, France

2. French Clinical Vaccinology Network (REIVAC)

3. Institut national de la santé et de la recherche médicale (Inserm), CIC BT 505 Cochin Pasteur, Paris, France

4. Cochin hospital, Paris, France

5. Vaccines Research, FISABIO-Public Health, Valencia, Spain

6. Department of Epidemiology, University Medical Centre Groningen, Groningen, the Netherlands

7. Department of Pharmacy, Unit of Pharmaco-Epidemiology & Pharmaco-Economics (PE2), University of Groningen, Groningen, the Netherlands

8. Centro de Investigación Biomédica de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain

9. Instituto de Salud Pública de Navarra, Pamplona, Spain

10. Department of Infectious Disease, Catholic University, Rome, Italy

11. Inserm, CIC 1001, Montpellier, France

12. Centre hospitalier régional universitaire (CHRU) Montpellier, Hôpital Saint Eloi, Montpellier, France

13. Department of Epidemiology and Prevention, IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli, Italy

14. Members are listed at the end of the article

Abstract

Binary file ES_Abstracts_Final_ECDC.txt matches

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference38 articles.

1. Influenza vaccine: The challenge of antigenic drift

2. Influenza vaccines. Wkly Epidemiol Rec. 2005;80(33):279-87. Available from: PMID: 16171031

3. Committee for Proprietary Medicinal Products (CPMP). Note for guidance on harmonization of requirements for influenza vaccines. London: European Medicines Agency; Mar 1997. CPMP/BWP/214/96. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003945.pdf

4. Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model

5. Correlates of vaccine protection from influenza and its complications

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seasonal Influenza Vaccine Effectiveness in Persons Aged 15–64 Years: A Systematic Review and Meta-Analysis;Vaccines;2023-08-04

2. Does repeated influenza vaccination attenuate effectiveness? A systematic review and meta-analysis;The Lancet Respiratory Medicine;2023-01

3. Spotlight influenza: Laboratory-confirmed seasonal influenza in people with acute respiratory illness: a literature review and meta-analysis, WHO European Region, 2004 to 2017;Eurosurveillance;2021-09-30

4. In-hospital and midterm out-hospital complications of adults hospitalised with respiratory syncytial virus infection in France, 2017–2019: an observational study;European Respiratory Journal;2021-08-26

5. Vaccine effectiveness against influenza A(H3N2) and B among laboratory‐confirmed, hospitalised older adults, Europe, 2017‐18: A season of B lineage mismatched to the trivalent vaccine;Influenza and Other Respiratory Viruses;2020-02-05